Viewing Study NCT06033820


Ignite Creation Date: 2025-12-25 @ 4:15 AM
Ignite Modification Date: 2025-12-26 @ 3:14 AM
Study NCT ID: NCT06033820
Status: RECRUITING
Last Update Posted: 2024-03-13
First Post: 2023-09-05
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Zanubrutinib+Lenalidomide+R-ICE in Relapsed/Refractory DLBCL
Sponsor: RenJi Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module